CClinicalTrials.gg
CompletedNCT00489034Updated Mar 6, 2017

Engaging Care for HIV-infected Adolescent Females.

An observational study in HIV Infection, sponsored by University of North Carolina, Chapel Hill. Completed at 5 sites in United States. Open to female participants aged 13 Years to 23 Years. Per ClinicalTrials.gov, last updated 2017-03-06.

Sponsored by University of North Carolina, Chapel Hill · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
178
Ages
13 Years to 23 Years
Sex
Female
01

Study summary

The proposed multi-site, longitudinal study will examine the correlation of substance use, mental health disorders, and social networks to engagement in care for HIV-infected adolescent females, aged 13 years, 0 months - 23 years, 11 months, and suggest ways to promote adherence and retention in treatment, care, and prevention programs. Qualitative and quantitative data collection methods will be used with index participants and network members.

Read the detailed description

The primary outcome examined in the proposed study is engagement in care, operationalized as the number of clinical visits attended. Clinic visits will be monitored on a weekly basis. Secondary outcomes of interest include medication adherence, sexual risk behaviors, and substance use. For the quantitative study, formal psychological testing will be conducted with index adolescent females, and biological specimens will be collected to validate self-reported drug use. CD-4 counts and viral load will be monitored every three months via chart review.

Index adolescents will be interviewed every six months (with phone interviews focused on service utilization at each six month interval midpoint) for eighteen months while network members will be interviewed at baseline and one year.

Qualitative interviews in the Ethnographic Study will be conducted with a small sub-sample of index and identified network participants from each site at least monthly for a period of at least 18 months. Qualitative interviews will be ethnographic in nature and will rely on participants' life stories and narratives of social experience to supply their content and to guide their progression.

Qualitative Interviews in the Gender Substudy will be conducted with a subsample of index participants. These qualitative interviews will focus on issues of gender related vulnerabilities and will be used to develop a survey to be administered to all index participants from sites participating in this substudy.

02

Conditions studied

  • HIV Infection

Browse trials for

Keywords

  • HIV
  • adolescent females
  • adherence
  • clinical care
  • risk behaviors
03

In context

HIV Infections

4,258 studies on the registry are indexed under HIV Infections; 240 are open to participants now.

This study's enrollment of 178 is below the median of 200 across 713 observational studies indexed under HIV Infections.

Browse HIV Infections studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 23 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

HIV-infected adolescent females, aged 13 years, 0 months - 23 years, 11 months will be followed to examine the correlation of substance use, mental health disorders, and social networks to engagement in care and suggested ways to promote adherence and retention in treatment, care, and prevention.

Eligibility criteria

Quantitative Study Inclusion Criteria

Index Participants:

  1. Female.
  2. Age 13 years, 0 months - 23 years, 11 months (364 days).
  3. All race/ethnicities.
  4. English or Spanish speaking.
  5. Non-perinatal, non-transfusion acquired HIV.
  6. Unknown transmission status with study personnel approval.

Network Participants:

Parents/Guardians of Index Participants:

  1. Know patient's HIV status
  2. Male or female.
  3. All race/ethnicities
  4. English or Spanish speaking.
  5. Serve a parental or guardian-like role.

Close Friend of Index Participants:

  1. Close friend of index subject.
  2. Male or female.
  3. Minimum age 13 years, 0 months.
  4. All race/ethnicities
  5. English or Spanish speaking

Ethnographic Sub-Sample

Inclusion Criteria:

Index Participants:

  1. Enrolled in Quantitative NIDA study.
  2. English-speaking at Miami, New York, Chicago, and New Orleans sites.
  3. English or Spanish-speaking at Los Angeles USC site

Network Participants:

  1. English-speaking at Miami, New York, Chicago, and New Orleans sites.
  2. English or Spanish-speaking at Los Angeles USC site.
  3. Know index serostatus.

Gender Sub-Sample

Inclusion Criteria:

  1. Age 18 years, 0 months - 23 years, 11 months.
  2. Enrolled in quantitative study.
  3. English-speaking.
  4. Female.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
178 participants (actual)

Groups and cohorts

  • Index Participants

    HIV-infected females, ages 13- 23 years, recruited from ATN sites in New York, Chicago, Miami, Los Angeles, and New Orleans will undergo quantitative interviewing. A sub-sample of the group will undergo ethnographic and/or gender interviewing.

    Behavioral: Quantitative Interview · Behavioral: Ethnographic Interview · Behavioral: Gender Interview

  • Network Participants

    Closest friends of index participants s and parents/guardians of index participants who know the index participant's HIV status will undergo quantitative interviewing. A sub-sample of the group will undergo ethnographic interviewing.

    Behavioral: Quantitative Interview · Behavioral: Ethnographic Interview

Interventions

  • BehavioralQuantitative Interview

    Index participants will be interviewed every six months (with phone interviews focused on service utilization at each six month interval midpoint) for 18 months while network members will be interviewed at baseline and one year. Interviews will consist of in-depth face-to-face and audio computer-assisted interviews (ACASIs) and a structured diagnostic interview to assess engagement in care (number of clinical visits attended), substance use, attitudes about substance use, friend's substance use, sexual risk behaviors, PTSD (for index participants only), support of index participants care use (network participants only), attitudes about healthcare (network participants only), index participant's adherence (network participants only), own functioning (network participants only), and family functioning (network participants only). At Baseline only, a urine sample will be collected from index participants for drug testing to assess the agreement between urine and ACASI.

  • BehavioralEthnographic Interview

    Qualitative interviews will be conducted with a small sub-sample of index and identified network participants from each site at least monthly for a period of 18 months. Interviews will be ethnographic in nature and will rely on participants' life stories and narratives of social experience to supply their content and guide their progression.

  • BehavioralGender Interview

    Qualitative interviews will be conducted with a sub-sample of index participants. These interviews will focus on issues of gender related vulnerabilities and will be used to develop a survey.

06

What researchers measure

Primary outcomes

  1. Engagement in Care among Index Participants

    Engagement in care will be operationalized as the number of clinic visits attended and will be assessed through the qualitative interviews.

    Time frame: Baseline, 6 months, 12 months, and 18 months

Secondary outcomes

  1. Medication Adherence

    As assessed through the qualitative interviews for index and network participants.

    Time frame: Baseline, 6 months, 12 months, and 18 months

  2. Sexual Risk Behaviors

    As assessed through the qualitative interviews for index and network participants.

    Time frame: Baseline, 6 months, 12 months, and 18 months

  3. Substance Use

    As assessed through the qualitative interviews for index and network participants.

    Time frame: Baseline, 6 months, 12 months, and 18 months

07

Study locations

5 sites
  • Universtiy of Southern California
    Los Angeles, California 90033, United States
  • University of Miami, School of Medicine
    Miami, Florida 33101, United States
  • Stroger Hospital of Cook County
    Chicago, Illinois 60612, United States
  • Tulane Medical Center
    New Orleans, Louisiana 70112, United States
  • Montefiore Medical Center
    Bronx, New York 10467, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00489034
Lead sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute of Mental Health (NIMH), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA)
Responsible party
Sponsor
First posted
Jun 21, 2007
Start date
Jul 2003
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Mar 6, 2017

Study contacts

Lori Perez, Ph.D
study director · Westat

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion